HIG WhiteHorse, a credit affiliate of global investment firm HIG Capital (HIG) has arranged a refinancing package for Grupo Hospitalario Recoletas (Recoletas), which includes a significant growth capital component.
Healthcare & Life Sciences
RiverGlade Capital (RiverGlade), a healthcare-focused private equity firm, has made threenew platform investments in the first six months of 2021 – Dynamic Infusion Therapy (DIT), Home Helpers Home Care (Home Helpers), and 2nd Chance Treatment Centers (2nd Chance).
Novo Holdings, an international life science investor, has co-led, alongside HealthCap and RA Capital Management, a USD55 million Series A financing in Hemab, a biotech company developing next generation therapeutics for serious underserved bleeding and thrombosis disorders.
Female wellness brand her1 has closed a Series A investment of EUR5.5 million, led by leading FoodTech investor Five Seasons Ventures.
ProductLife Group (PLG) expands its international footprint in India and Central Europe with ELC acquisition
After having acquired French-based AxPharma and US-based DS InPharmatics, PLG has continued the expansion of its international footprint with the acquisition of ELC.
The Riverside Company, a global private investor focused on the smaller end of the middle market, has invested in eMindful, a provider of evidence-based, mindfulness programmes for everyday life and chronic conditions.
Coave Therapeutics, a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases, has raised an additional EUR21.2 million (USD25.1 million) of Series B funding, bringing the total raised to EUR33.1 million (USD39 million).
Aromyx, a specialist in applying biotechnology and data science to capture unique sensory data, has closed an oversubscribed USD10 million Series A round of financing led by Rabo Food&Ag Innovation Fund and SOZO Ventures.
LeapFrog Investments, a Profit with Purpose investment firm, has invested USD30 million in India’s leading health and wellness app, HealthifyMe.
XPhyto Therapeutics Corp is to acquire 3a-diagnostics, Frickenhausen, Germany (3a), the company's exclusive diagnostics development partner.